Masaaki Hanaoka
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tolvaptan improves the diurnal blood pressure profile in patients with hypertension and autosomal-dominant polycystic kidney disease.
Journal: American journal of hypertension
Published: November 11, 2025
Effects of sodium zirconium cyclosilicate on the quality of life of patients with hyperkalemia undergoing hemodialysis: Y-QOL study design.
Journal: BMC nephrology
Published: June 27, 2025
Clinical Course and Factors Correlated with Severe Morbidity and Mortality in Patients with Coronavirus Disease 2019 Undergoing Maintenance Dialysis in Kanagawa, Japan.
Journal: Internal medicine (Tokyo, Japan)
Published: September 29, 2024
Blunted humoral immune response to the fourth dose of BNT162b2 COVID-19 vaccine in patients undergoing hemodialysis.
Journal: Clinical and experimental nephrology
Published: December 24, 2022
The implication of calf circumference and grip strength in osteoporosis and bone mineral density among hemodialysis patients.
Journal: Clinical and experimental nephrology
Published: October 16, 2022
Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients.
Journal: Kidney international reports
Published: August 05, 2022
SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
Journal: Clinical and experimental nephrology
Published: March 23, 2022
A case of minimal change nephrotic syndrome with pregnancy.
Journal: CEN case reports
Published: October 27, 2020
Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
Journal: Cardiovascular diabetology
Published: May 17, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026